Abstract Background: The role of class II P fimbriae (P fimbriae II) in diabetic kidney infections is uncertain, although some genetic and epidemiological studies suggest a lower prevalence of P fimbriae II genes in Escherichia coli strains isolated from diabetic patients with complicated kidney infections. Methods: We inoculated a P fimbriae II deficient E. coli (DH5aT) or an isogenic P fimbriae II expressing transformant (DH5aTP) into the bladders of diabetic and non-diabetic BALB/C mice, and sacrificed them after 3 days. The incidence of bladder or kidney infection (!10 3 CFU of E.
Introduction
Among the known and putative virulence factors of uropathogenic Escherichia coli (UPEC), class II P fimbriae (P fimbriae II) have the strongest association with kidney infection (pyelonephritis). 1e3 However, studies of the roles of P fimbriae II in the development and severity of E. coli infections in the kidneys of patients with diabetes mellitus (DM) have produced discordant results. Some studies reported a decreased prevalence of the papG II gene (encoding class II P fimbrial adhesin) in UPEC isolated from DM patients with complicated urinary tract infections (UTIs) 4, 5 but others reported an increased prevalence of P fimbriae or papG II in UPEC isolated from DM patients with urosepsis or bacteremia. 6, 7 Thus, an animal model of DM and UTI may help to identify the roles of P fimbriae II in the pathogenesis and severity of kidney infections in the presence of DM.
The receptor-binding PapG adhesin is located at the tip of P-fimbriae, 8 and the receptors for PapG adhesin are on the surface of the uroepithelial cells of human, other primates, and mice. 9e11 Among the various types of adhesins in UPEC, class II P fimbrial adhesin (PapG II), which recognizes the major a-D-gal-1-4-b-D-gal globoside-containing isoreceptors that are abundant in the renal tissue of humans and mice, 9, 10 have a strong association with renal infection in humans. 1, 4 Binding of adhesins at the tip of P fimbriae to the uroepithelial receptors leads to innate immunity of the urothelium in human epithelial cells and normal mice. 12, 13 At the molecular level, attachment of PapG II adhesin to its receptor leads to the release of ceramide, an agonist of Toll-like receptor 4 (TLR4) 14 that stimulates signaling pathways leading to activation and translocation of NF-kB and transcription of proinflammatory genes, such as IL-6 and IL-8. 15 The approach of the present animal study differs somewhat from a previous report. 16 Here, we utilized a less virulent E. coli strain that is deficient in P fimbriae II and lacks most virulence factors, and transformed this strain so that it expresses isogenic P fimbriae II. This approach allows us to directly test the effects of P fimbriae II on the pathogenesis and severity of E. coli infection in diabetic kidneys. In addition, we evaluated the intensity of cytokine expression in the renal tubules of infected kidneys to investigate the potential roles of host cytokine response in the pathogenesis of kidney infection in the presence of DM.
Methods Ethics statement
All procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC Approval No: 100050) of National Cheng Kung University and all methods were performed in accordance with the relevant guidelines and regulations.
Bacterial strains, plasmids transformation, and testing for P-and type 1-fimbrial phenotypes Non-pathogenic E. coli DH5a expresses type 1-fimbriae, but is deficient in P-fimbriae and lacks most virulence genes. 17 The pACYC184 (GenBank/EMBL accession number X06403)-derived plasmid pPIL110-35 (kindly provided by Dr. James R Johnson, University of Minnesota), carries a 16-kb EcoRI fragment from the AD110 pap gene cluster encoding class II P-fimbriae. 18 Bacterial transformations were carried out according to Kushner. 19 The strain transformed with pACYC184 (expressing only type 1-fimbriae) was designated as DH5aT, and the strain transformed with pPIL110-35 (expressing the type 1 and P fimbriae II) was designated as DH5aTP.
Expression of P fimbriae II was indicated by mannoseresistant hemagglutination to human types A1P1 and OP1 and sheep erythrocytes; expression of type 1 fimbriae was indicated by mannose-sensitive hemagglutination to guinea-pig erythrocytes. 20 
Experimental animals
Six to eight week-old BALB/c female mice were rendered diabetic by intraperitoneal injection of Streptozotocin (STZ; Sigma Chemical Co., St Louis, USA) or carrier alone (non-diabetic controls) using a modification of the method of Rosen et al. 16 In brief, mice were fasted for 4 h, and then given 200 mg of STZ per kg of body weight by intraperitoneal injection. Non-fasting blood glucose levels were measured daily beginning 5 days after STZ injection by monitoring glucose level in venous blood drawn from the tail (Lifescan, Inc., Milpitas, Calif). A mouse was considered diabetic after two consecutive readings greater than 250 mg/dL.
Mouse model of ascending UTI
The mouse model of ascending UTI was based on that of Johnson and Brown 21 with modification. 22 Female diabetic (n Z 20) or non-diabetic (n Z 20) mice were anesthetized with intraperitoneal pentobarbital. A polyethylene catheter was inserted through the urethral orifice into the bladder until resistance was felt, and then withdrawn several mm. Then 50 mL of bacterial suspension (5 Â 10 8 CFU/mL of E. coli) was inoculated via the catheter. Mice were sacrificed 3 days after bacterial challenge. Upon killing, the mouse blood was aspirated, and the left kidney and bladder were removed and homogenized aseptically for quantitative culture. Infection of the kidney or bladder was defined as at least 10 3 CFU of E. coli per organ. Bacteremia was defined as at least 10 2 CFU of E. coli on blood culture plate.
Renal pathology
The right kidney of diabetic mice infected with DH5aTP or DH5aT were sectioned through the central region to view the papilla, medulla, and cortex. Sections were stained with hematoxylin and eosin and evaluated by a blinded pathologist. This pathologist graded the severity of renal pathology using a scoring system in which 0, 1, 2, and 3 indicated normal, mild, moderate, and severe pyelitis, respectively; and 4 and 5 indicated mild to moderate, and severe pyelonephritis, respectively. 23 The mean pathological score is presented for each group.
Immunohistochemistry
A modified version of a previously described IHC protocol was used. 24 Formalin-fixed, paraffin-embedded kidney sections (5 mm thick) were de-waxed and treated with ImmunoRetriever Citrate (Bio SB Inc., Santa Barbara, CA, USA) in a pressure cooker for 15 min at 100 C. Endogenous peroxidase activity was suppressed by incubating sections in a de-peroxidase reagent (Bio SB Inc., Santa Barbara, CA, USA) at room temperature for 10 min. All IHC experiments used mouse-generated primary antibodies at a dilution of 1:50 for anti-IL-6 (Leica Microsystems Inc., Bannockburn, IL, USA), 1:250 for anti-IL-8 (GeneTex Inc., Irvine, CA, USA), and 1:50 for anti-TNF-a (GeneTex Inc., Irvine, CA, USA). Kidney sections were labeled with a reagent, and stained with DAB substrate-chromogen solution using the mouse/ rabbit PolyDetector HRP/DAB detection system (Bio SB Inc., Santa Barbara, CA, USA). All sections were then counterstained with hematoxylin. A section of mouse kidney was used as a positive control. A negative control was performed by incubation with 1% mouse serum without the primary antibody.
Immunohistochemical evaluation
The intensity of IL-6, IL-8 and TNF-a immunostaining was evaluated semiquantitatively using the following categories: 0 (no staining), 1þ (weak, but detectable, staining), 2þ (moderate or distinct staining), and 3þ (intense staining). 25 The resulting Histo-score (H-score) 25 The number of bacteria attached to the renal tubules may correlate positively with the degree of tissue cytokine expression. Therefore, we also calculated a "corrected Hscore", which is the ratio of the H-score to the bacteria count (log 10 CFU).
Urinary levels of interleukin-6 (IL-6) and interleukin-8 (IL-8)
Urine were obtained at sacrifice of mice and were immediately centrifuged, separated, frozen and stored at À70 C until they were tested in batches. IL-6 and IL-8 levels were measured by enzyme-linked immune sorbent assay (ELISA) using commercially available kits according to the manufacturer's instructions (eBioscience, San Diego, California). Cytokine levels (pg/ml) were calculated from standard curve generated with recombinant cytokines. All samples were measured in duplicated by ELISA.
Statistics
Differences in the percentage of mice with bladder or kidney infections and bacteremia were compared by Fisher's exact test or the c 2 test, as appropriate. Quantitative culture results were logarithmically transformed and compared using ANOVA for within-group comparisons and Student's t-test for inter-group comparisons. The intensity of immunostaining and urinary levels of cytokines in diabetic and non-diabetic mice was compared by the ManneWhitney U test. Data were expressed as means AE standard errors of the mean (SEM). All statistical analyses were performed using JMP software (SAS Institute Inc., Cary, NC, USA). A p value less than 0.05 was considered significant.
Results

Characterization of E. coli phenotypes
We used E. coli strain DH5aT, which expresses the MSHA phenotype but has no MRAH activity, and strain DH5aTP, which strongly agglutinates human A1P1, OP1, and sheep RBCs with and without mannose in the medium. Thus, DH5aT expressed only the type 1 fimbriae phenotype, but DH5aTP had the type 1 phenotype and the class II P fimbriae phenotype.
Virulence in the diabetic and non-diabetic BALB/c mouse model of ascending UTI.
Bladder infection When challenged with E. coli DH5aT, only 20% of the nondiabetic mice had bladder infections by day 3, but 90% of the diabetic mice had bladder infections (!10 3 CFU of E. coli per bladder) (Table 1) . Similarly, when challenged with E. coli DH5aTP, only 10% of the non-diabetic mice had bladder infections by day 3, but all the diabetic mice had bladder infections.
Further analysis indicated that the geometric means of bladder bacterial counts were significantly greater in diabetic than non-diabetic mice following infection by DH5aT and DH5aTP (Fig. 1a) . Although diabetic and non-diabetic mice had different responses, DH5aT and H5aTP had similar effects on bladder infection and bladder bacterial counts within each group (Table 1 and Fig. 1a) .
Kidney infection
When challenged with E. coli DH5aT, neither the diabetic nor the non-diabetic kidneys were infected by day 3 (Table  1) . However, when challenged with DH5aTP, 20% of the non-diabetic mice had infected kidneys (!10 3 CFU of E. coli per kidney) and all the diabetic mice had infected kidneys. The geometric mean bacterial count in DH5aTP-infected diabetic mouse kidneys was significantly higher than those in the other three groups (Fig. 1b) .
Bacteremia
There was no bacteremia (!10 2 CFU on blood culture plate) by day 3 in non-diabetic mice challenged with E. coli DH5aT or DH5aTP (Table 1 ). In contrast, bacteremia occurred in 80% of the diabetic mice infected with DH5aTP and in 10% of the diabetic mice infected with DH5aT (DH5aTP vs. DH5aT, P Z 0.006) ( Table 1) .
Renal pathological findings and pathological scores in diabetic mice
When inoculated with E. coli DH5aT, 2 of the diabetic mice showed no inflammation in the renal pelvis and parenchyma, but the other 8 exhibited inflammatory cells beneath the epithelial lining of the pelvic cavity (pyelitis, arrows in Fig. 2a) . In contrast, infection of diabetic mice with DH5aTP led to destruction of kidney parenchyma tissue architecture (within the arrowheads in Fig. 2b ) and infiltration of inflammatory cells (arrows in Fig. 2b ). Highpower magnification of DH5aTP-infected kidneys from diabetic mice showed collections of rod-like bacteria in the renal parenchyma (arrows in Fig. 2c) . The mean renal pathology score was significantly higher for diabetic mice inoculated with E. coli DH5aTP than DH5aT (2.9 AE 1.9 vs. 1.1 AE 0.7, P Z 0.009).
Immunohistochemistry of IL-6, IL-8, and TNF-a in mouse kidneys following DH5aTP infection
We also measured renal cytokine production following infection of diabetic and non-diabetic mice with DH5aTP.
Il-6. There was a weak expression of IL-6 in the renal tubules of diabetic mice (Fig. 3a) , but greater expression in the renal tubules of non-diabetic mice (Fig. 3b) . Quantification of these results by H-score indicated no significant difference (24 AE 6 vs. 65 AE 35, P > 0.05; Fig. 4a) . However, the corrected IL-6 H-score (ratio of IL-6 H-score to log 10 CFU in the infected kidney) was significantly lower in the diabetic than non-diabetic mice (4.8 AE 0.5 vs. 18 AE 0.1, P Z 0.045; Fig. 4b ).
Il-8. There was a weak expression of IL-8 in the renal tubules of diabetic mice (Fig. 3c ), but greater staining in the renal tubules of non-diabetic mice (Fig. 3d ). The IL-8 Hscore was significantly lower in the diabetic than nondiabetic mice (25 AE 3 vs. 65 AE 25, P Z 0.04; Fig. 4a ) and the corrected IL-8 H-score was also significantly lower in the diabetic than non-diabetic mice (4.5 AE 0.5 vs. 18 AE 0, P Z 0.04; Fig. 4b ).
TNF-a. There was a weak-to-moderate but localized TNF-a staining in the renal tubules of diabetic mice (Fig. 3e) , but stronger and more diffuse expression in the renal tubules of non-diabetic mice (Fig. 3f) . However, there were no significant differences in the H-scores (20 AE 10 vs. 24 AE 5, P > 0.05; Fig. 4a ) or corrected TNF-a H-scores (5.5 AE 0.5 vs. 4.4 AE 0.8, P > 0.05; Fig. 4b ).
Urinary levels of interleukin-6 (IL-6) and interleukin-8 (IL-8)
Urine were obtained at sacrifice of mice on day 3 after bacterial inoculation. The urinary levels of IL-6 and IL-8 were compared between diabetic and non-diabetic mice. The results revealed that both the urine IL-6 and IL-8 levels of diabetic mice were lower than that of non-diabetic mice, although there was no statistical significance (IL-6: 9.7 AE 3.6 vs. 18.8 AE 6.7 pg/ml, P > 0.05; IL-8: 6.5 AE 2.5 vs. 7.9 AE 3.5, P > 0.05).
Discussion
The STZ-induced diabetic mouse model of UTI has many of the same characteristics as UTIs in humans with DM, and is therefore a powerful tool for examination of uropathogenesis in the presence of DM. 16 We used BALB/c mice to conduct the STZ-induced diabetic mouse model of ascending UTI because these mice express the receptors for class II P fimbriae adhesins on the renal epithelium. Previous research indicated that the orientation of a promoter on a 314-bp invertible element controls expression of type 1 fimbriae genes. 26 More specifically, cystitis strains switch the invertible element to the "on" position, where it remains as infection progresses; pyelonephritis strains turn the switch to the "on" position early during infection, and then turn the switch "off". Both DH5aT and DH5aTP can express type 1 fimbriae and can cause bladder infections, but only the transformant with the class II pap gene cluster expressed P fimbriae II by switching "off" the invertible element, and this (or possibly by some other factors) allowed ascent into the renal pelvis and development of pyelonephritis.
We previously showed that P fimbriae II can enhance the early establishment (day 1 after inoculation) of E. coli infection in the kidney, but that kidney infection did not persist to day 3 in normal immunocompetent mice. 22 In the present study, we also found that most of the bacteria were cleared from the kidneys of non-diabetic mice by day 3. Previous studies showed that P fimbriae II can activate receptor-bearing uroepithelial cells, and promote the release of IL-6 and IL-8. 27 The strain DH5aTP (expressing P fimbrial II) triggers a sufficiently strong cytokine response so that it is cleared from the kidney tissues of normal mice, but not diabetic mice. In contrast, the kidneys of diabetic mice had elevated bacterial counts, and pathological examination of their infected kidneys showed significant accumulation of bacteria and tissue destruction.
Rosen et al. previously demonstrated that the effects of diabetes on the burden of UPEC (E. coli UTI89) in mouse kidneys was significantly greater in immunocompetent C3H/HeN mice than in C3H/HeJ mice, which harbor a mutation in the Toll-like receptor 4 (TLR-4) signaling domain. 16 They therefore suggested that the defects in TLR-4-regulated innate immune factors may explain the increased colonization of UPEC in diabetic kidneys. In this study, we compared the cytokine response of diabetic and non-diabetic mice by direct measurement of IL-6 and IL-8 expression, which are the end-products of TLR4-mediated innate immunity and can be stimulated by the binding of P fimbrial adhesin II to its receptors on the surface of renal tubules.
14 The H-score of IL-8 and the corrected H-score of IL-6 were lower in the infected kidneys of diabetic mice than non-diabetic mice, although these groups had comparable expression of TNF-a. This is compatible with the previous finding that P fimbriated E. coli triggered IL-6 and Figure 3 . Representative photomicrographs of immunohistochemistry in diabetic and non-diabetic mouse kidneys with infection. Weakly positive IL-6 (a) and IL-8 (c) staining (brown) was occasionally seen in the renal tubules of diabetic mice (original magnification, Â200). More diffuse IL-6 (b) and IL-8 (d) staining was found in the renal tubules of non-diabetic mice (original magnification, Â200). Weak to moderate, localized TNF-a staining revealed in the renal tubules of diabetic mice (e). Weak, but more diffuse TNF-a expression was found in the renal tubule cells of non-diabetic mice (f) (original magnification, Â200).
IL-8, but not TNF-a. 27 These findings imply that an impaired cytokine response may contribute to the increased incidence and severity of kidney infections in diabetic hosts. Geerlings et al. found that women with DM and asymptomatic bacteriuria (ASB) had lower urinary levels of IL-6 and IL-8 than non-diabetic women with ASB. 28 Our present study also revealed lower urine levels of IL-6 and IL-8 of diabetic mice when compared with that of non-diabetic mice, although there was no statistical significance that may be due to small sample size.
In our model, the diabetic mice developed impaired cytokine responses soon after the onset of DM. Thus, it is possible that their lower cytokine production was the result of a cellular defect due to the altered cell environment in the kidney. A previous study demonstrated that high glucose-induced TGF-b 1 production suppressed the immune response by inhibiting the endogenous production of cytokines, including IL-6. 29 However, the results of other studies are inconsistent with this interpretation. 30 The present study also revealed that diabetic mice were more susceptible than non-diabetic mice to bladder infection with both the type 1-fimbriated strains DH5aT and DH5aTP. Geerlings et al. found that E. coli expressing type 1-fimbriae adhere better to the uroepithelial cells isolated from the urine of women with DM compared with those isolated from women without DM. 31 Our result is consistent with epidemiological observations of an increased incidence of cystitis in diabetic patients. 32 In summary, our study demonstrated that the incidence of kidney infection and bacteremia and kidney pathological score were significantly increased only when the diabetic mice were infected with P-fimbriae II expressing E. coli. We also revealed a lower cytokine expression in the renal tubules of diabetic mice with kidney infection. We concluded that the P-fimbriae II contributes to the development and severity of E. coli infection in the kidneys of diabetic hosts. An impaired cytokine response to the P-fimbriated E. coli may be one of the mechanisms for the increased incidence and severity of kidney infections in diabetic hosts.
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